Myriad Autoimmune (formerly known as Crescendo Bioscience) develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients with autoimmune and inflammatory diseases. It provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians. The company also offers Vectra solution which is a blood test for rheumatoid arthritis (RA) disease activity.